Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry

Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry

Objectives The objectives of this study were to describe the demographic profile and baseline disease characteristics of patients with psoriatic arthritis (PsA) treated with either infliximab (IFX), subcutaneous golimumab (GLM) or ustekinumab (UST) treatment in Canadian routine care setting along wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Emmanouil Rampakakis, Proton Rahman, Majed Khraishi, Maqbool Sheriff, Dalton Sholter, Allen J Lehman, François Nantel, Regan Arendse
Format: Article
Language:English
Published: BMJ Publishing Group 2020-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/8/e036245.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items